COVID-19 Clinical Resource Links

Division of Pediatric Hematology-Oncology

´╗┐Developmental Therapeutics and Pharmacology Research Program utilizes a combination of UNC investigator-initiated, cooperative group and pharmaceutically-led trails to offer a range of options when precision medicine approaches are indicated or when standard therapies have failed.

The Adolescent and Young Adult (AYA) Research Program focuses on providing research options for patients 13-26 years old.

The Hematopoietic Stem Cell Transplant Research Program seeks to improve outcomes for pediatric patients who require hematopoietic stem cell transplantation for the possibility of long-term survival.

The Epigenetics and Translational Research Program investigates the relationship between chromatin organization, dysregulated transcription factors, and epigenetics in pediatric and adult solid tumors, in particular, Ewing sarcoma and renal cell carcinoma.

The Cellular Therapy Research Program focuses on T-cell therapy and ways in which white blood cells (called T-cells) can be re-engineered so as to recognize and kill cancerous cells.

The Hemostasis and Thrombosis Research Program seeks to provide cutting edge service for the evaluation and treating of patients with bleeding or clotting disorders.